Ticker Symbol: AEON+

AEON Biopharma Inc. - Warrants (28/02/2028)

Exchange: NYSE MKT LLC Currency: USD Asset Type: Warrant CIK:0001837607

Company Profile

we are a nasdaq-listed special purpose acquisition company whose business purpose is to effect a merger or similar business combination with one or more businesses. our acquisition strategy is to identify and complete our initial business combination with a medical technology company in the healthcare industry. our sponsor team consists of chairman/ceo robert palmisano, president vikram malik, cfo oleg grodnensky and chief legal officer david meredith.

Sector: Professional, Scientific, and Technical Services

Industry: Research and Development in Biotechnology

Standard Industrial Classification Code (SIC code): 2834

Address: N/A

Website: N/A

CEO: N/A

Tags: N/A

Pricing

Last Updated: October 20, 2023 03:00 PM EST

Previous Close: $0.11

Change: $0.00 ( -2.83%)

Days Range: $0.11 - $0.11

Beta: -

52wk. High: $0.36

52wk. Low: $0.00

Ytd. Change 138.40%

50 Day Moving Average: $0.13

200 Day Moving Average: $0.11

Shares Outstanding: 9200000

Valuation

Market Cap: 1.2B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A